Power up your LNP and AAV sample prep with Unagi
ON-DEMAND By Unchained Labs
Watch this on-demand webinar to see first-hand data results demonstrating the power and flexibility of Unagi for nucleic acids, LNPs and AAVs.
List view / Grid view
Webinars
CHO targeted integration platform for accelerated antibody development
ON-DEMAND By Sartorius
Watch this webinar to hear from Dr Yuansheng Yang as he introduces a CHO cell-based technology allowing simultaneous display and secretion of antibodies for accelerating the process of antibody development.
Decoding cancer and inflammation: identifying selective inhibitors of SH2 domains
ON-DEMAND By Eurofins Discovery
Watch our on-demand webinar where our expert speaker will explore the possibilities for designing selective small molecules targeting the SH2 domains of STAT proteins plus more.
Engineering cell lines for rare disease research and precision therapeutics
ON-DEMAND By Sartorius
Want to learn about the latest research and development of cell models in rare diseases? Then watch this virtual panel discussion to hear from industry experts.
How 3D biology is shaping the future of drug discovery
ON-DEMAND By Molecular Devices & HeartBeat.bio
Watch this virtual panel discussion to identify ways to overcome common challenges in 3D biology research, regardless of where you are in your journey.
Comprehensive in vitro approach to evaluate transporter-mediated drug interactions in drug discovery
ON-DEMAND By Eurofins Discovery
In this on-demand webinar, an assay strategy to assess transport-mediated drug interactions that complies with regulations is examined.
How robotics enable process automation in the modern laboratory
ON-DEMAND By Brooks Automation
Watch this on-demand webinar to learn how collaborative robots are improving accuracy and efficiency in today’s laboratories.
Roundtable: Accelerating your biologics therapeutics development with bioassays
ON-DEMAND By Eurofins DiscoverX
Watch this on-demand virtual roundtable to explore how the simple, thaw-and-use bioassay format improves assay workflow and helps attain high assay reproducibility.
Leveraging the E3scanTM technology platform for next-generation targeted protein degradation
ON-DEMAND By Eurofins Discovery
Watch our free on-demand webinar to learn how to accelerate screening and Structure Activity Relationship (SAR) analysis in the targeted protein degradation (TPD) drug discovery field.
Improving Huntington’s disease drug discovery with new reproducible disease models
ON-DEMAND By bit.bio
This webinar explores how a new generation of reproducible and scalable human cell models are being utilised for drug discovery in Huntington’s disease.
Assays for protein degradation therapeutics to accelerate undruggable proteome discoveries
ON-DEMAND By PerkinElmer and C4
Looking for a way to address the undruggable proteins in the human body? Watch this free on-demand webinar where industry experts discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.
An efficient and effective PIM3 kinase-focused screening cascade for identification of multiple novel and tractable hit series
ON-DEMAND By Eurofins Discovery Services
Watch this free on-demand webinar to understand how to rapidly identify selective, specific, potent and tractable hit series with appropriate ADME characteristics to speed up hit-to-lead.
timsTOF MALDI PharmaPulse, a trapped ion mobility-enabled mass spec solution for label-free HTS in drug discovery
ON-DEMAND By Bruker Daltonics
Watch our free on-demand webinar to discover how the new timsTOF MPP product solution, with its dedicated MALDI PharmaPulse 2023 HTS software suite, improves data quality and accelerates high-throughput screening in drug discovery.
Image-based, quantitative approaches to study SARS-CoV-2 cell entry and infection: looking for the Achilles’ heel of virus infection
ON-DEMAND By Yokogawa Deutschland GmbH
Watch our free on-demand webinar to discover how fully automated imaging and image analysis can provide the unprecedented possibility to follow single viral particles, including for SARS-CoV-2.
Unlocking orphan GPCRs with an innovative forward trafficking approach
ON-DEMAND By Eurofins DiscoverX and Sanford Burnham Prebys Medical Discovery Institute
Watch this on-demand webinar to learn about orphan GPCRs as drug targets and the challenges related to lead identification.
